ANDA 76361, held by Teva. Levofloxacin.
As of Nov 16, 2026, ANDA 76361 (Levofloxacin), held by Teva, was first approved by FDA on Jun 20, 2011, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Rx |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 17Labeling · Standard review | Approved | None posted |
| Sep 9, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 13Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Sep 19, 2014 | Supplement 8Labeling · Standard review | Approved | None posted |
| Sep 19, 2014 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 15, 2014 | Supplement 1Manufacturing | Approved | None posted |
| Oct 22, 2012 | Supplement 6Labeling · Standard review | Approved | None posted |
| May 24, 2012 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 10, 2012 | Supplement 3Labeling | Approved | None posted |
| Oct 20, 2011 | Supplement 2Labeling | Approved | None posted |
| Jun 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters